Launch Bexoveld active in North America
Deadline not yet reached (796 days left)
- Announced
- 3 Aug 2023
- Due
- 31 Dec 2028
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Corteva expects to launch Bexoveld™ active in North America in 2028 and in Europe in 2030, pending regulatory reviews.”
What we found
The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 31 Dec 2028.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- Bexoveld active
- Where
- North America
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: pending regulatory reviews
- Depends on
- Regulatory
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you Corteva? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-CTVA-014749 · Corrections policy